Ernst & Young

AGESCO 35

Fic Expertise

Sygnatures

Y2A Experts

OVHcloud, a leading provider of high-performance cloud infrastructure, has announced a collaboration with Bware Labs, a leading developer of Blockchain APIs.

Bware Labs and OVHcloud Join Forces for Lightning-Fast Blockchain API Platform


Rome - The end of November and the beginning of December are expected to be freezing in Europe, with a wave of cold and snow that persists until the Immaculate Conception. This...

Intense Cold and Rainfall

Eli Lilly have announced the appointment of Olivia Burston as Senior IT Business Analyst - MES.

Eli Lilly appoints Olivia Burston to Senior IT Business Analyst - MES

Alexandria Real Estate Equities, Inc., a leading owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses, has announced an exclusive partnership with Eli Lilly and Company to expand Lilly's innovative Gateway Labs model to the San Diego life science cluster.

Alexandria Real Estate Equities and Lilly Partner to Expand Gateway Labs in San Diego

A Senior Consultant - Controle de Gestion has announced their departure from GRANT THORNTON France. Emna Mezghani leaves to join Thomson Broadcast as Responsable du contrôle de gestion.

GRANT THORNTON France loses Senior Consultant - Controle de Gestion to Thomson Broadcast

Believe and Time Records renew their agreement: the joint adventure between an absolute leader in the field of global digital music distribution and one of the most fascinating and atypical stories of

Believe and Time Records renew their agreement

The drug “Mounjaro” could soon be approved in the EU for obesity treatment. A new plant is to be built in Rhineland-Palatinate as an investment of billions for this purpose.

How does Eli Lilly's new slimming syringe work?

Eli Lilly have appointed Jonathan L to Sr. Director - Gene/Cell Therapy Engineering. They join the company from CSL, where they served as Senior Manager, Site Engineering.

Eli Lilly appoints Jonathan L as Sr. Director - Gene/Cell Therapy Engineering

Eli Lilly plans to invest 2 billion euros in a new plant in Alzey, western Germany, a source close to the negotiations told Reuters on Thursday.

Eli Lilly to Invest 2 Billion Euros in New German Plant

The pharmaceutical company Lilly is inviting you to a prominent press conference in Berlin on Friday. What insiders report could then be announced: A new production facility is to be built in Germany. However, there should be a big difference to other major investments.

Select a company within accounting within saint-jacques-de-la-lande